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INTRODUKSJON: På verdensbasis rammes 10-15 % av befolkningen av infertilitet, og 50 % 
av parene som søker om assistert befruktning gjør dette på grunn av nedsatt sædkvalitet. 
Sædkvaliteten er nært knyttet til oksidativt stress (OS). På grunn av spermienes store 
energibehov og svake antioksidant mekanismer har spermiene vanskeligheter med å forsvare 
seg mot OS produsert både eksogent og endogent. Vitamin C og/eller vitamin E er 
antioksidanter med evne til å redusere OS, og kliniske utprøvninger viser forbedringspotensiale. 
Gurkemeie er en ekstrem potent, lipofil antioksidant som har vist potensiale i behandling av 
flere sykdommer hos mennesker, men dårlig biotilgjenglighet har så langt begrenset 
gurkemeies kliniske bruk. For å bedre biotilgjengeligheten til gurkemeie er nanoteknologi tatt 
i bruk. Det er derfor interessant å undersøke om nanoteknologi-baserte liposomer kan øke den 
antioksidative effekten av gurkemeie. Dette for å oppnå forbedret bevegelighet og levedyktighet 
av spermier in vitro. 
FORMÅL: Målet med denne oppgaven var å demonstrere antioksidativ aktivitet av gurkemeie, 
samt å undersøke om en liposom-formulering med gurkemeie kan øke denne antioksidative 
aktiviteten og forhåpentligvis forbedre bevegelighet og levetiden til spermiene in vitro.  
METODE: Liposomer med gurkemeie ble fremstilt ved bruk av film-metoden og 
filterekstrudering. Den antioksidative effekten av gurkemeie ble testet med ABTS- og DPPH-
redoksindikatorer, og sammenlignet med vitamin C og vitamin E. Effekten av tomme 
liposomer, liposomer med gurkemeie, fritt gurkemeie, vitamin C og vitamin E ble bestemt ved 
å observere bevegeligheten og levedyktigheten til spermier in vitro. 
RESULTATER: Liposomene med gurkemeie hadde en størrelse på 147,82 ±17,3 nm, og av 
tilsatt gurkemeie var 88,84 ± 2,31 % inkorporert i liposomene. EC50 for gurkemeie ble funnet 
til å være 5,82 µM i ABTS og 9,13 µM i DPPH. Antioksidantene som fritt gurkemeie, vitamin 
C og vitamin E opprettholdt bevegeligheten og levedyktigheten i opptil 24 timer. Lipid i 
konsentrasjoner over 0.5 µg/ml viste toksisk effekt på spermiene.  
KONKLUSJON: Liposomene med curcumin var uniforme i størrelse og hadde en høy 
inkorporeringsevne. Det ble bekreftet at gurkemeie hadde antioksidative egenskaper, og studien 
viser at liposomale lipider overraskende hadde negativ effekt på levedyktigheten til spermiene. 
Flere studier med flere paralleller må midlertidig utføres før dette kan bekreftes.  









INTRODUCTION: Worldwide, 10-15 % couples are infertile, and 50 % of the couples seeking 
assisted reproductive techniques do so because of defective sperm quality. The semen quality 
can be directly linked to oxidative stress (OS). Due to high metabolic rates and weak anti-
oxidant systems, sperm cells are unable to defend against OS produced exogenously and 
endogenously. Vitamin C and/or vitamin E are anti-oxidants showing promising outcome to 
reduce OS, but the clinical application has not been fully achieved. Curcumin is an extremely 
potent lipid-soluble anti-oxidant showing potential in therapy for different human disorders, but 
its poor bioavailability has limited its wider use. Nanotechnology has been used for the purpose 
of improving the bioavailability of curcumin. It would be interesting to apply nanotechnology 
based liposomal delivery of curcumin, a noted anti-oxidant for the enhancement of motility and 
viability of human sperm cells in vitro. 
OBJECTIVES: With this study, the aim was to prove anti-oxidative activities of curcumin. We 
also studied if liposomal formulation of curcumin could maximize the anti-oxidative activities 
and hopefully enhance motility and viability of sperm cells in vitro.  
METHODS: Curcumin loaded liposomes were made by the film method followed by extrusion. 
Anti-oxidative activities of free curcumin were tested with ABTS and DPPH assay methods 
and compared with vitamin C and vitamin E. The effect of empty liposomes, liposomal 
curcumin, free curcumin, vitamin C and vitamin E was determined by observing the motility 
and viability of sperm cells in vitro.  
RESULTS: Liposomes with curcumin had an average size of 147.82 ±17.3 nm and entrapment 
efficiency of 88.84 ± 2.3 %. The EC50 for curcumin was 5.82 µM in ABTS and EC50 9.13 µM 
in DPPH assay, respectively. Anti-oxidants such as curcumin, vitamin C and vitamin E 
maintained the motility and viability up to 24 hours, however lipid showed toxicity to sperm 
cells at 0.5 µg/ml or higher concentrations.  
CONCLUSION: The liposomes containing curcumin were uniformly distributed with high 
entrapment efficiency. We confirmed anti-oxidative activity of curcumin, however, rather 
unexpectedly that the liposomal lipid has shown negative effect on sperm viability at certain 
concentrations. Further studies with more replicates are needed to confirm these findings. 
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Nanomedicine is defined by the National Institutes of Health in the USA as “the use of 
nanotechnology for treatment, diagnosis, monitoring and control of biological systems” 
(Moghimi et al., 2005). The physical definition of nanomedicine states nanostructured materials 
in medicine that have a size between 1 and 100 nm (Wagner et al., 2006). It should be noted 
that the treatment of diseases based on drug particle size is a recently developed medical field. 
The publication and patent activities on nanomedicines have risen rapidly since year 2000 
(Figure 1). This shows that nanotechnology in the medical field has gained tremendous interest 
because of enabling functions to existing products making them competitive. 
Nanopharmaceutics are favoured in biomedicine mostly because of their promising properties 
as drug delivery systems (Wilczewska et al., 2012, Naahidi et al., 2013, Barkalina et al., 2014). 
Drug delivery systems are developed for the improvement in bioavailability and 
pharmacokinetics in therapeutics. An example of this kind is a market product “Ambisome” 
which is a liposomal formulation based drug that showed reduced toxicity to kidney with 
improved fungicide function (Wagner et al., 2006). Drug delivery systems are the main area 
and are accounting for more than 75 % of the total sales in the field of nanomedicine (Wagner 
et al., 2006). Twenty three nanomedicines based drug delivery systems were already available 
commercially in 2006 (Wagner et al., 2006), and the number was rapidly increased to 71 in 
2013 (Etheridge et al., 2013). 
 





Nanotechnology was first applied for cancer diagnostics and treatment by destroying unwanted 
cells with high precision. The improvement of nanotechnology and safety have led to expansion 
in use of nanotechnology in different non-cancer applications. Among one of them is 
reproductive medicine (Barkalina et al., 2014). 
Application of nanomaterials for therapeutic purpose has been competitive to conventionally 
established theories because of changed chemical, physical and biological properties due to 
particle size (1-100 nm). Compared to other bulk solid materials, nanomaterials are more 
controlled of quantum mechanics than material physics (Barkalina et al., 2014). 
Characteristics of nanomaterials are the particle size ranges from 1 to 1000 nm as well as the 
type of materials. Most of the market products as nanomaterial drugs had a particle size between 
100 and 200 nm in 2013 (Figure 2)(Etheridge et al., 2013). Small sizes of nanoparticles have 
shown better integrating possibilities into cellular processes and physiological pathways 
without interfering with normal biological system. Nanomaterials used in the drug delivery 
have great potentials to carry large amounts and different types of biological cargo. Nanosystem 
protect drug from rapid clearance and degradation by reticuloendothelial system (RES). Surface 
can be modified to react with environmental factors giving responsive drug release 
(Wilczewska et al., 2012, Naahidi et al., 2013, Barkalina et al., 2014). 
 
Figure 2: Mean size of nanocomponents in nanomedicine applications reached marked or under investigation in 
2013 (Etheridge et al., 2013) (with permission). 
 
With all these functionalities that nanotechnology can contribute with, it is interesting to 
see if nanotechnology can be applied for the improvement of sperm quality. In this 
context, it would be interesting to know whether some anti-oxidant incorporated 





 Liposomal characteristics 
In 1965, the first description of swollen phospholipid systems was published, and these closed 
bilayer membrane systems are what we today call liposomes (Deamer, 2010). Liposomes are 
vesicles, consisting of a uni-, oligo- or multi-lamellar lipid bilayers surrounding aqueous core 
and are most commonly used as drug delivery systems (Wagner et al., 2006, Spuch and 
Navarro, 2011). 
Liposomes are formed by dispersing amphiphilic compounds in aqueous media (Sharma and 
Sharma, 1997). When an amphiphilic compound comes in contact with water, the polar head 
groups interact with the water, while the tails interact with each other and parts from the aqueous 
medium. This forms a bilayer membrane. The advantage of this bilayer structure is that it is 
possible to entrap hydrophilic compounds and/or incorporate hydrophobic compounds in the 
lipid layer as shown in Figure 3 (Hupfeld et al., 2006). 
 
Figure 3: An unilamellar liposome with hydrophilic drug in aqueous compartment and lipophilic drug 





 Membrane component - phosphatidylcholine 
One of the most used amphiphilic compounds to form the liposomal membrane are the 
phospholipids (New, 1990). One of the most common phospholipids used is 
phosphatidylcholine (PC) from egg or soy (New, 1990, Fiume, 2001, Spuch and Navarro, 
2011). 
The structure of PC molecule consists of two long fatty acid chains, often stearic, palmitic or 
oleic acids combined by a glycerol bridge (Fiume, 2001). The glycerol bridge connects the 
hydrophilic head which makes the amphiphilic structure to PC as shown in Figure 4 (New, 
1990). The hydrophilic head comes from a positively charged choline group and negatively 
charged phosphate oxygen and carbonyl oxygen atoms (Pasenkiewicz-Gierula et al., 1999). 
Phosphoric acid is linked to the α-position of glycerol bridge in natural, but it can be attached 
in the β-position as well (Fiume, 2001). 
 
Figure 4: Chemical structure of zwitterionic soy- phosphatidylcholine (PC). 
 
PC is one of the components in lecithin (Patil et al., 2010). Soy lecithin is confirmed safe by 
the World Health Organization (WHO) and has been awarded Generally Recognized as Safe 
(GRAS) status by the US Food and Drug Administration (FDA) (World Health, 1974, Fiume, 
2001). PC in concentration from 0.1 to 3.0 mM shows no significant effect on human sperm 
motility (Hong et al., 1986). Because of PCs safety and low costs, PC is often used to form the 





 Classification of liposomes  
Liposomal classification after shape, size and number of bilayers: 
Small unilamellar vesicle (SUV): consist of one single layer of membrane with diameter 
between 10 and 100 nm (Sharma and Sharma, 1997, van Swaay and deMello, 2013). 
Large unilamellar vesicle (LUV): consist of one single layer of membrane with diameter 
between 100 and 1000 nm (Sharma and Sharma, 1997, van Swaay and deMello, 2013). 
Giant unilamellar vesicle (GUV): consist of one single layer of membrane with size up to 1 µm 
(van Swaay and deMello, 2013).  
Multilamellar vesicle (MLV): consist of many layers of membrane with diameter usually over 
100 nm (Sharma and Sharma, 1997, van Swaay and deMello, 2013). 
Multivesicular vesicle: consist of small vesicles inside a bigger vesicle (Sharma and Sharma, 
1997, van Swaay and deMello, 2013).  
 
Figure 5: Liposomes classified after their size and number of bilayers. SUV = small unilamellar vesicle, LUV = 
large unilamellar vesicle and GUV = giant unilamellar vesicle (van Swaay and deMello, 2013) (with permission). 
 
 Liposomes in drug delivery  
The first liposomal formulation that was approved by the US Food and Drug Administration 
was Doxil® in 1995, for the treatment of chemotherapy refractory acquired immune deficiency 
syndrome-related Kaposi’s sarcoma (Chang and Yeh, 2012). The liposomal formulation gave 
a significantly change improved distribution and elimination, and doxorubicin was more 
concentrated in the tumour area (Northfelt et al., 1996). 
Experiments show that some drugs incorporated or encapsulated in liposome gets less 
eliminated from plasma, and improved drug distribution compared to non-incorporated or non-




human cell membrane, which gives them good compatibility and low toxicity. Inserting drugs 
inside a vehicle make the drug more secured from degradation and sensitive tissues will be less 
affected (Gregoriadis, 1973, Allison, 2007). The possibilities of modifying liposomes can 
precisely locate and hold the drug concentration in a therapeutic level, without affecting 
immunological attack (Spuch and Navarro, 2011).  
Conventional liposomes are the term used for liposomes that often consists of neutral and/or 
negatively charged phospholipid and cholesterol (Sharma and Sharma, 1997). They are taken 
up by endocytosis and deliver its contents to lysosomes, which are roughly explained in Figure 
6. Liposomal size between 10-100 nm have shown optimal pharmacokinetic properties in vivo, 
while smaller are renally cleared and bigger are removed by RES in liver and spleen (Allen and 
Chonn, 1987, Sharma and Sharma, 1997, Wilczewska et al., 2012, Naahidi et al., 2013, 
Barkalina et al., 2014, Hafner et al., 2014).  
 
Figure 6: A modified schematic drawing showing the cellular uptake increases when a poor absorbed drug is 
incorporated in liposomal formulation. Here are curcumin illustrated as orange dots (Spuch and Navarro, 2011) 
(with permission). 
 
It is clear that liposomal formulation increases solubility and cellular uptake for those drugs 
having poor solubility and bioavailability. Liposomal formulation of curcumin was chosen 
because numerous liposomal formulations are done for tumour cells and red blood cells (Anand 
et al., 2007), but there are no articles found for sperm cells. It could be interesting to know 
whether a poorly soluble anti-oxidant, such as curcumin, once incorporated in liposomes can 




1.3 Role of anti-oxidants in male infertility 
Infertility is defined as “Women of reproductive age at risk of becoming pregnant and report 
unsuccessful pregnancy for more than two years” (Mascarenhas et al., 2012). Almost fifty 
percent of the couples seeking for assistance reproductive techniques are because of not optimal 
semen quality (Jensen et al., 2013). This can either be caused by low sperm count, reduced 
sperm motility or sperm with abnormal morphology (Krausz, 2011, Mascarenhas et al., 2012). 
The defective semen quality has been attributed mainly to the reactive oxygen species (ROS) 
and thus produced oxidative stress (OS). 
ROS are produced during cellular metabolism and needed for maintaining normal cellular 
physiology including spermatogenesis and fertilizing ability. However, overproduction of ROS 
can lead to dysfunction of sperms and 30-80 % of ROS related pathology is reported in infertile 
patients. High ROS levels are linked with OS, giving defective sperm functions and birth 
defects (Sharma and Agarwal, 1996, Gilbert and Colton, 2002, Bansal and Bilaspuri, 2010, 
Aitken and Koppers, 2011, Agarwal et al., 2014). 
The source for ROS production is in the electron transport chain in the mitochondria (Murphy, 
2009, Bratic and Larsson, 2013). ROS are involved in generation of OS and oxidative damage. 
Mainly involved free radicals are superoxide anion (O2-), hydroxyl (OH), nitric oxide (NO) and 
peroxynitrite (ONOO-) while the non-free radical species are hydrogen peroxide (H2O2) and 
nitrous acid (HNO2) (Bansal and Bilaspuri, 2010, Basnet and Skalko-Basnet, 2011). 
 
Figure 7: Presentation of the electron transport chain and mechanisms involved in free radical production (Chen 




A detailed mechanism of production of ROS is explained by a schematic diagram in Figure 7. 
A sudden ROS exposure affects most mitochondrial proteins that can result in ATP-
synthesizing impairment (Chen and Zweier, 2014) and impairment in signalling (Droge, 2002). 
A long time exposure of ROS can addition to the damages as in sudden exposure also damage 
cellular proteins (Stadtman and Levine, 2000). This can lead to lipid peroxidation (Rubbo et 
al., 1994, Murphy, 2009) and DNA impairing (Turrens, 2003, Chen and Zweier, 2014). 
Since sperm cells have limited capacity to defend against ROS and/or free radicals, DNA and 
other organelles can be damaged and affect the fertility and fetus development. It has been 
thought that intake of some anti-oxidants like fruits, grains and vegetables can have favourable 
effect against oxidative stress (Halliwell, 1994, Gilbert and Colton, 2002, Bansal and Bilaspuri, 
2010, Agarwal et al., 2014). Among several anti-oxidants, vitamin C and vitamin E are two 
important anti-oxidants found in the natural sources and are practiced clinically for the 
improvement of semen quality (Kessopoulou et al., 1995, Verma and Kanwar, 1998, Agarwal 
et al., 2003, Lanzafame et al., 2009, Bansal and Bilaspuri, 2010). 
On the other hand, curcumin is a well-known anti-oxidant that has been gaining a lot of interest 
markedly the past two decades because of its potent anti-oxidative and anti-inflammatory 
properties in the preclinical tests. In spite of its high potential as a therapeutic drug, it clinical 
application for treatment of human diseases is limited because of low solubility and poor 
bioavailability (Aitken, 1999, Bansal and Bilaspuri, 2010, Gupta et al., 2012, Chen et al., 2013, 
Walczak–Jedrzejowska et al., 2013, Agarwal et al., 2014). 
With this in mind, the purpose with this study is to see whether anti-oxidative potentials of 
curcumin can be utilized to reduce oxidative stress in sperm cells, and effect can be maximized 
by using nanotechnology as the liposomal formulation. Hopefully, it could be the tool in the 






1.4 Curcumin  
 Origin of curcumin 
Curcumin, also known as diferuloylmethane, is a polyphenol and mainly derived from dried 
rhiozomes from the plant Curcuma longa Linn, also known as “Turmeric” (Sharma et al., 2005, 
Goel et al., 2008, Padhye et al., 2010, Basnet and Skalko-Basnet, 2011). Turmeric has been 
used for treatment purposes to different inflammation, metabolism, respiratory and skin 
diseases in Ayurvedic medicine, which is one of the world’s oldest medical systems (Sharma 
et al., 2005, Goel et al., 2008, Padhye et al., 2010, Mahajan, 2011) 
 
Figure 8: A: The plant Curcuma longa Linn, B: Rhizome of the plant and C: Turmeric powder. Pictures are taken 
from Wikipedia (A and C) and B are published with permission (Basnet and Skalko-Basnet, 2011). 
 
 Main components in turmeric 
Curcuminoids such as Curcumin I, Curcumin II and Curcumin III are major components which 
are 3-4 % of turmeric and their structures are illustrated in Figure 9 (Chattopadhyay et al., 2004, 
Basnet and Skalko-Basnet, 2011). Among the three curcuminoids, curcumin I or simply called 
as curcumin is not only highly abundant compound but also biologically active one. Curcumin 
product that is available in the market is not pure curcumin but rather a mixture of curcuminoids 





Figure 9: The three main curcuminoids presented in turmeric (Basnet and Skalko-Basnet, 2011). 
 
The structure of curcumin was first identified in 1910 by Milobedzka and synthesized in 1913 
by Lampe (Gupta et al., 2012). One of the first scientific papers showing pharmacological 
activity of curcumin was published in 1949 according to PubMed database, National Institute 
of Health. The interest on curcumin have been expanded since then and gained most interest 
markedly the past two decades which can be illustrated by the number of publication as shown 
in Figure 10. This is because of the promising therapeutic potentials shown by curcumin (Gupta 
et al., 2012). The pharmacological effects of curcumin are studied in animals as well as humans. 
Although based on PubMed database, different routes of administration such as orally, 
topically, intravenously and intraperitoneally were used, but the optimal therapeutic effects 
remained challenging due to its low solubility and poor bioavailability. 
 
Figure 10: Number of publications on curcumin listed in PubMed database, National Institutes of Health (March 
2015). 



















































 Chemical properties of curcumin  
The general chemical characteristics of curcumin are mentioned in Table 1. Curcumin consists 
of two para- hydroxyl groups, two keto groups, two ortho- methoxy groups, an active 
methylene group and two double bonds (Pandey et al., 2011). Curcumin has two isomers, enol- 
and keto- form as shown in Figure 11. 
Table 1: Chemical properties of curcumin 




diene-3,5-dione (Shen and Ji, 2007) 
Molecular formula: C21H20O6 (Padhye et al., 2010) 
Molecular weight: 368,37 g/mol (Padhye et al., 2010) 
pKa: 8,55 (Jovanovic et al., 1999) 
Maximum absorption peak 
(λmax): 
In methanol occurs at 420 – 430 nm (Sharma et al., 2005, 
Padhye et al., 2010) 
Bioavailability: Poor (Basnet and Skalko-Basnet, 2011) 
Solubility: Insoluble in water and ether. Soluble in acetone, dimethyl 
sulfoxide, ethanol, and methanol (Goel et al., 2008, Padhye 
et al., 2010, Grynkiewicz and Ślifirski, 2012) 
Light sensitive: Yes (Sharma et al., 2005) 
 
 
Figure 11: Molecular and optimized structure of curcumin in enol- and keto- form. 
 
The structure of the enol- form is planar while the keto- form can be twisted in a cis- or trans- 
formation (Wright, 2002, Shen and Ji, 2007). Enol- form of curcumin is more stable that the 
keto- form, and the cis-diketo form is the most unstable of them all (Wright, 2002). It can be 
thought that because of the physiological pH, the keto- form will be dominating in cellular 




Curcumin has a strong visible yellow colour that comes from the two benzene-parts on each 
side of the carbon chain conjugation (Shen and Ji, 2007). The enol- form of curcumin dominates 
in basic pH and has a red colour, while the keto- form has a light yellow colour (Goel et al., 
2008). 
 
 Anti-oxidative activities of curcumin 
Anti-oxidants in general are “compounds and reactions that dispose, scavenge and suppress 
formation of ROS or oppose their actions” (Bansal and Bilaspuri, 2010).  
Anti-oxidants have three main functions (Agarwal et al., 2014): 
1) Works as chelators or binding proteins  
2) Prevents formation of ROS  
3) Remove ROS that are already present 
Curcumin is polyphenolic phytochemical provided through diet. Most polyphenols have similar 
chemical nature showing anti-oxidative properties by the hydrogen atom transfer and single 
electron transfer mechanisms. 
The hydrogen transfer mechanism is based on donating hydrogen atom, mostly from the phenol 
to free radicals as shown in equation A. This mechanism is dependent on bond dissociation 
energy (BDE) meaning that the lower BDE, the more efficient and rapid the donation will 
happen. The results of this mechanism are that the free radical are neutralized and phenoxy 
radical will be produced which is more stable and less reactive than the free radical (Quideau 
et al., 2011). 
(A)  H-atom transfer:  R• + ArOH  RH + ArO•  
The second mechanism is the single-electron transfer where an electron from the phenol are 
transferred to a free radical as shown in equation B. This mechanism is dependent on ionization 
potential of the phenol.  
(B) Single-electron transfer: R• + ArOH  R- + ArOH+• 
Therefore, curcumin as a polyphenol compound is able to show anti-oxidant properties by both 





 Safety and tolerability of curcumin 
Curcumin has been taken daily in the form of curry spices (turmeric) up to 2 g per day daily in 
South Asian countries such as Nepal and India (Basnet and Skalko-Basnet, 2011). In the phase 
I clinical trial, up to 12 g per day orally administered curcumin was found non-toxic and 
tolerated (Lao et al., 2006, Shen and Ji, 2007). Goel et al. reported that toxic doses of curcumin 
is far above the therapeutic effective doses (Goel et al., 2008). Curcumin did not show 
teratogenic effects (World Health, 1974). Curcumin is considered safe and approved by FDA 
(Basnet and Skalko-Basnet, 2011). 
Even though the studies showing high tolerability and safety of curcumin, it is important to 
keep in mind that none of the studies are performed directly so far in our knowledge on human 
sperm. The purpose of selecting curcumin for the current research aim was also due to its safety 





1.5 Semen  
Half of the infertility is contributed by the male factor, mainly because of semen quality. The 
assisted reproductive technology (ART), mainly in vitro fertilization (IVF), has helped 
infertile/sub fertile couples to conceive baby. However there are further possibilities to develop 
ART by increasing semen quality.  
During ART, germ cells are at risk for being exposed to high levels of ROS (Bansal and 
Bilaspuri, 2010). This can happen during microscopy because of exposure to light, different 
oxygen levels and temperature. 
 
Figure 12: Picture of sperm cells observed under light microscope (x200). 
 
Defective sperm functions are the most common cause of male infertility and difficult to treat. 
Among these, it is well known that oxidative stress contributes to the fertility status of sperm 
cells (Walczak–Jedrzejowska et al., 2013). Therefore by reducing the OS with supplement of 





  ROS and OS in human sperm cells 
Spermatozoa also called sperm cells are male gametes. Sperm cell consists of head (5.1 µm 
size), neck (7 µm long) and tail (45 µm long) (World Health, 2010) which are also shown in 
the light microscopic picture in Figure 12. A schematic diagram of a sperm cell is shown in 
Figure 13. Because of rapid movement of tail, it is a highly motile cell. Only motile sperm cells 
can bring fruitful fertilization, and therefore are the viability of the sperm cells expressed due 
to its motility. Sperm cells are rich in mitochondria because of its constant need for energy 
required for their rapid and constant movement. For electron transfer to happen in the electron 
transport chain, oxygen is required. Sperm cells have limited anti-oxidant mechanisms 
compared to other human cells. This is the reason to ROS accumulation in sperm cells leading 
to OS (Agarwal et al., 2003, Agarwal et al., 2014).  
 
Figure 13: A modified figure of a sperm cell and two systems that generates reactive oxygen species (ROS) 
(Agarwal et al., 2014). 
 
Sperm cells consist of intracellular lipid which contributes to energy production. By oxidizing 





Two systems are involved in ROS generation in the human sperm cell as shown in Figure 13 
(Bansal and Bilaspuri, 2010, Agarwal et al., 2014); 
1) The nicotinamide adenine dinucleotide phosphate oxidase system in sperm plasma 
membrane (NADPH oxidase) 
2) The nicotinamide adenine dinucleotide-dependent oxidoreductase reaction in the 
mitochondria (NADPH-dependent oxidoreductase) 
The anti-oxidant mechanism in sperm cells are limited. ROS have physiological functions and 
are necessary for normal process of cell proliferation, differentiation and migration. Despite the 
importance of ROS for the fertilization and other physiological functions, defective sperm 
functions are linked with OS produced by the excessive ROS production. And the defective 
sperm function induced by endogenously and exogenously produced ROS is the most common 
cause of male infertility as shown in Figure 14 (Sharma and Agarwal, 1996, Gilbert and Colton, 
2002, Bansal and Bilaspuri, 2010, Agarwal et al., 2014).  
 




 Extracellular anti-oxidant protection 
Since the anti-oxidative mechanisms of sperm cells are less effective, can intake of some anti-
oxidants like fruits, grains and vegetables have favourable effect (Halliwell, 1994, Gilbert and 
Colton, 2002, Bansal and Bilaspuri, 2010, Agarwal et al., 2014).  
Literatures support that infertile men have higher levels of OS than fertile male, and infertile 
men have lower anti-oxidant levels in seminal plasma than fertile men. Supplement of anti-
oxidants are therefore thought to have potentials in protecting against OS and can be used for 
the management of male infertility. Such anti-oxidant therapy usually involves oral anti-oxidant 
supplementation and in vitro supplementation in the culture medium in ART (Halliwell, 1994, 
Sharma and Agarwal, 1996, Gilbert and Colton, 2002, Bansal and Bilaspuri, 2010, Chen et al., 
2013, Agarwal et al., 2014). As shown in Figure 15, free radicals or ROS are generated by 
inducing endogenous and exogenous sources. Hydroxyl lipid radicals can damage cellular 
function of the sperm cells. However, anti-oxidant can dilute the OS by strengthening cellular 
anti-oxidant systems and scavenging ROS or free radicals. 
 
Figure 15: Summarized illustration of anti-oxidants scavenging ability on reactive oxygen species (ROS) and 
inhibition of lipid peroxidation. 
 
Therefore, current research project is focused on a strong anti-oxidant, curcumin and to enhance 









2 AIM OF THE STUDY 
Application of nanotechnology in the field of medicine has been progressing rapidly. The 
therapeutic effects of the drugs associated with nanocarrier of the particle size (1-100 nm), 
differ comparing to conventional dosage forms. Recent advancement of nanotechnology based 
liposomal drug delivery are mainly improved: 1) the solubility of the drug, 2) the stability of 
the drugs, 3) the delivery to the targeted sites, and 4) the bioavailability and cellular uptake. 
The outcome was the optimal therapeutic effects with reduced side effects.  
On the other hand, a part of infertility treatment and/or improvement of assisted reproductive 
technology (ART) can further be achieved by the improvement of semen quality. Due to the 
high metabolic rates and weak anti-oxidant systems, sperm cells are unable to defend 
themselves against the oxidative stress (OS) produced exogenously or endogenously. Vitamin 
C and/or vitamin E as anti-oxidants are supplemented in the culture media in the preparation of 
semen during IVF procedure. In spite of promising outcome, the clinical application has not 
been fully achieved. It would be interesting to apply nanotechnology based liposomal delivery 
system for curcumin, a well-known anti-oxidant for the enhancement of motility and viability of 
human sperm cells in vitro. 
Therefore, the main aim of the study was to develop curcumin incorporated in liposomal 
delivery system, and apply for the enhancement of motility and viability of human sperm 
cells in vitro. 
We hypothesize that liposomal formulation will improve curcumin solubility and cellular 
uptake by the sperm cells. Therefore, optimal and homogenous concentration of curcumin will 
be achieved inside and outside of the sperm cells. Like that, produced excessive ROS and OS 
can be controlled which may lead to the increased motility and viability. 
Moreover, anti-oxidant capacity and effects of curcumin on the sperm motility and viability 
will be compared with that of vitamin C and vitamin E under the similar experimental 
conditions. This study will be a preliminary pilot study and carried out for the first time. 
Therefore, the main focus will be on the development of methods. The findings will serve as 
the base for further study improvement of semen quality by using nanotechnology based 









3 MATERIAL AND INSTRUMENTS 
3.1 Materials  
ABTS, 2,2’-Azino-bis (3-ethyl benzothiazoline-6-sulfonic acid) diammonium salt (ABTS), 
Sigma Aldrich Co., St. Louis, USA 
Alpha-tocopherol, Sigma-Aldrich, Steinheim, Germany 
Ascorbic acid, Sigma-Aldrich Co., St. Louis, USA 
Curcumin FLUKA Curcumin purum, Sigma-Aldrich, Steinheim, Germany 
DMSO, Dimethyl sulfoxide, Sigma Aldrich chemie GmbH, Steinheim, Germany 
DPPH, 2,2-Diphenyl-1-picrylhydrazyl free Radical (DPPH), Sigma-Aldrich®, St. Louis, USA 
Ethanol, Sigma-Aldrich, Chemie GmbH, Steinheim, Germany 
Lipoid S100 (> 94 % phosphatidylcholine), Lipoid GMBH, Ludwigshafen, Germany 
Methanol, Chromasolv®, Sigma-Aldrich, Chemie GmBH, Steinheim, Germany 
Methanol, E.Merck, Darmstadt, Germany 
Methylene blue hydrate Ph.Eur., Sigma Aldrich, Steinheim, Germany 
Modified HTF Medium, Irvine Scientific, Waalwijk, Netherlands 
Potassium peroxidisulfate, Merck, Darmstadt, Germany 
Quinn’s Advantage® Protein Plus Fertilization (HTF), In-Vitro Fertilization Inc, Trumbull 
USA. 





3.2 Equipment and instruments 
Agilent 8453 UV-Visible Spectrophotometer, Agilent Technologies, Santa Clara, USA 
Büchi Rotavapor R-124 with Büchi Vac V-500 Vacuum Pump System, Büchi Vacuum 
Controller B-721 and Büchi Water bath B-480, Büchi labortecknik, Flawil, Switzerland. 
Centrifuge Heraeus D-37520 Osterode Biofuge Pico, Heraeus Instruments, Germany 
Biofuge pico Heraeus Instruments, Germany. 
Centrifuge Tubes with Screw Caps, VWR North America, USA 
Conical Centrifuge Tubes, Thermo Fisher Scientific, New York, USA 
Distillation unit Distinction D4000, Bibby Sterlin LDT, Staffordshire, UK 
FALCON® 96-Well Cell Culture Plates, Corning Incorporated, New York, USA 
FormaTM Series II 3110 Water-Jacked CO2 Incubator, Thermo Scientific, USA 
Improved Neubauer 0.100 mm depth, 0.0025 mm2 counting chamber, Glaswarenfabrik Karl 
Hecht, Rhön, Germany 
Leitz Fluovert FU inverted microscope, Wild Leitz GmBH, Germany 
Menzel-Gläser British Standard Microscope slides, Thermo Fisher Scientific Inc., Waltham, 
USA 
Menzel-Gläser Circle Cover Slips, Thickness 1.5, Thermo Fisher Scientific Inc., Waltham, 
USA 
NICOMP Submicron particle sizer, model 370, Nicomp Particle sizing systems, Santa Babara, 
California, USA. 
Nucleopore® Track-Etched Membranes (PC) Polycarbonate, size 0.8 µm, 0.4 µm, 0.2 µm, 0.1 
µm, Whatman International Ltd., Maidstone, UK. 
Open-top UV quartz Cell cuvette, 10 mm, 3.0 ml volume, Agilent Technologies, Germany. 
SONICS High Intensity Ultrasonic Processor, 500 Watt Model with Temperature Controller, 
probe diameter 13 mm, Sonics & Materials Inc., Newtown, USA. 
SuperClear® Centrifuge Tubes with Plug Style Caps, Labcon North America, USA 




Vortex Genie2TM, Bender & Hobeinag, Zürich, Switzerland. 
Zeiss 10x and 40 x objective lenses, Carl Zeiss, West Germany 
Zeiss Standard Binocular Microscope, Carl Zeiss, West Germany 
Zetasizer Nano Zen 2600, Malvern instruments Limited, Engima Business Park, Grovewood 





3.3 Computer programs 
Büchi Rotavapor R-124 with Büchi Vac V-500 Vacuum Pump System with Büchi Vacuum 
Controller B-721 and Büchi Water bath B-480, Büchi, Switzerland 
NICOMP Particle Sizing Systems, CW388 Application Version 1.68, Santa Barbara, 
California, USA. 
NICOMP Submicron particle sizer, model 370, Nicomp Particle sizing systems, Santa Babara, 
California, USA 
SONICS High Intensity Ultrasonic Processor, 500 Watt Model with Temperature Controller, 
probe diameter 13 mm, Sonics, Newtown, USA  
UV-Visible ChemStation SoftwareB.04.02, Agilent Technologies 2001-2011, Germany. 
Vortex Genie2TM, Bender & Hobeinag, Zürich, Switzerland 
Zetasizer Nano Zen 2600, Malvern instruments Limited, Engima Business Park, Grovewood 
Road, Malvern, Worcestershire, UK 





4 EXPERIMENTAL SECTION 
4.1 Preparation of liposomes 
 Preparation of empty liposomes 
Lipoid S100 (200 mg) was weighted in a 100 ml round bottom flask and dissolved in sufficient 
methanol. A Büchi Rotavapor R-124 with Büchi Vac V-500 Vacuum Pump System, Büchi 
Vacuum Controller B-721 and Büchi Water bath B-480 (Büchi labortecknik, Switzerland) were 
used to hydrate the lipid. The set up was adjusted to 50 mmHg, 45 °C and 70 rpm. The rotation 
was adjusted to 94 rpm when all the organic solvent evaporated, and when the pressure was 
around 60 mmHg, the flask was immersed deeper into the water bath. By optimal pressure, the 
lipid film evaporated in one hour and the potential traces of solvent were removed by flushing 
with nitrogen gas for one minute. Lipid film was resuspended quickly in 10 ml distilled water, 
and a vortex was used to mix properly and dislodge all film from the flask bottom and walls. 
The liposomes were stored in the refrigerator for 12 hours before further experiments.  
 
 Preparation of liposomes with curcumin 
Curcumin (20 mg) and Lipoid S100 (200 mg) were weighted, dissolved in methanol, evaporated 
and liposomes resuspended in distilled water as shown in Section 4.1.1. Most of the lipids were 
removed from the flask wall by using a vortex and ultrasonic bath for one minute to remove 
lipid from the flask bottom. Curcumin loaded liposomes were stored in the refrigerator for 12 
hours before further experiments.  
 




4.2 Liposomal characterization 
 Size reduction of liposomes 
 Sonication 
SONICS High Intensity Ultrasonic Processor 500 Watt Model with Temperature Controller 
(Sonics & Materials Inc., USA) was used to reduce the size of liposomes. Liposomal suspension 
was transferred to a 10 or 20 ml beaker and put into an ice bath. The probe was positioned in 
the centre of the suspension, without touching the bottom or the glass walls. The suspension 
was exposed to ultrasound with an output of 50 Watt for continuous 2 minute cycles to achieve 
the desired particle size of 100 nm. The liposomes were stored in the refrigerator at 4 °C for 24 
hours before further analysis. 
 
 Extrusion 
Nuclepore® polycarbonate membranes (Whatman International Ltd., UK) at sizes 800, 400, 
200 and 100 nm were used as filter for extrusion of liposomes. Liposomes (10 ml) were first 
vortex for 2 minute before being transferred to a syringe (10 ml). The liposomes were extruded 
through the filter five times for each respective pore size. After extrusion, the liposomes were 
placed in the fridge for minimum 2 hours before further experiments. 
 
 Vesicle size determination 
A NICOMP Submicron particle sizer model 370 with Helium-Neon diode laser operating at 
632.8 nm (NICOMP, USA) was used to determine the liposome sizes and distribution. Test 
tubes were rinsed with distilled water and afterward put in an ultrasonic bath for 10-15 minute. 
The sample preparation was made in laminar airflow bench to avoid possible contamination 
with dust particles. Test tubes were cleansed with fresh filtered distilled water (0.22 µm pore 
size syringe filter) before the suspension was diluted to an intensity of 250-350 kHz 
(Ingebrigtsen and Brandl, 2002), before the measurement. Each suspension was measured for 
3 times10 minute cycles at a fixed angle of 90° to the incident light. The results were presented 





 Zeta potential determination 
A Zetasizer Nano Zen 2600 (Malvern, UK) was used to measure zeta potential. The cell was 
cleansed with 96 % ethanol and rinsed with filtrated tapped water. One ml syringes were used 
to clean and fill the cell with suspension. The suspension was prepared by diluting liposomes 
1:20 (v/v) with filtrated tapped water. The measurement was set to 3 cycles and 100 runs. 
 
 Spectral analysis 
A stock solution of curcumin and 96 % ethanol with concentration 100 000 ng/ml was prepared. 
The stock solution was gradually diluted until a spectrum with maximum absorbance peak 
(λmax) around 2 was measured in Agilent 8453 UV-vis spectrophotometer with deuterium and 
tungsten lamp using an open-top UV quartz Cell cuvette (10 mm, 3,0 ml volume) (Agilent 
Technologies, USA). The limit of spectral analysis was at 12 500 ng/ml concentration. 
 
 Standard curve of curcumin  
Absorbance was measured on a spectrophotometer as described in Section 4.2.4. A standard 
curve was made from a stock solution at 100 000 ng/ml diluted to the concentrations 1000, 800, 
600, 400, 200 and 100 ng/ml with 96 % ethanol. The measuring wavelength was set to 425 nm. 
A standard curve was made by plotting absorbance against the concentration of standard 
solutions. 
 
 Separation of un-incorporated curcumin 
Extruded liposomal suspensions were centrifuged on Heraeus Biofuge Pico centrifuge (Heraeus 
Instruments, Germany) to separate liposomes from un-incorporated curcumin. The 
centrifugation had a speed at 1000 g for 10 minute. The pellet with un-incorporated curcumin 
and supernatant with liposomal curcumin were separated, weighted and volume was determined 





 Entrapment efficiency 
Entrapment efficiency was measured with a spectrophotometer as in Section 4.2.4. Each 
liposomal suspension was first disintegrated with 96 % ethanol before diluting to a measurable 
absorbance. The entrapment efficiency was measured by the following equation: 




A: amount of curcumin in supernatant, B: amount of curcumin in pellet 
 
 Stability testing  
The stability of empty liposomes and liposomes incorporated with curcumin were determined 
by measuring the vesicle size after 5 months of storage in 4 °C. The measurements were 





4.3 Anti-oxidative activities 
Anti-oxidative activities is expressed as the capacity of curcumin, vitamin C and vitamin E to 
scavenge chemically generated free radicals such as 2,2’-Azino-bis(3-ethyl benzothiazoline-6-
sulfonic acid) diammonium free radical (ABTS+•), and 2,2-Diphenyl-1-picrylhydrazyl free 
radical (DPPH•) by the standard methods (Basnet et al., 1997, Re et al., 1999). 
 
 Preparation of ABTS+• and DPPH• solution 
The ABTS+• solution was prepared by mixing 1:1 (v/v) ABTS solution (7.4 mM) with 
potassium peroxidisulfate (PPOS) solution (2.6 mM) and diluted four times with 96 % ethanol.  
DPPH• solution (120 µM) was prepared by solubilizing DPPH with 96 % ethanol. 
 
 Spectral analysis of ABTS+• and DPPH•  
A spectral analysis were carried out by mixing 300 µl of free radical solution (ABTS+• or 
DPPH•) with 300 µl 96 % ethanol. The absorbance was measured in a Agilent 8453 UV-vis 
spectrophotometer with deuterium and tungsten lamp using an open-top UV quartz Cell cuvette 
(10 mm, 750 µl volume) (Agilent Technologies, USA). 
 
 Determination of anti-oxidant activities of vitamin C, vitamin E and 
curcumin by ABTS or DPPH radical scavenging assay 
ABTS+• and DPPH• solution were made as described in Section 4.3.1. Vitamin C (10 mM) was 
prepared by solubilizing ascorbic acid with distilled water. One mM solution was prepared 
mixing 10 mM vitamin C solution 1:10 (v/v) with 96 % ethanol. Vitamin E (1mM) and 
curcumin (1 mM) solution were prepared by solubilizing with ethanol.   
Each anti-oxidant solution were diluted to the concentrations 1, 5, 10 and 20 µM. ABTS+• or 
DPPH• solution were mixed 1:1 (v/v) with each anti-oxidant and left in dark at room 
temperature (24 °C) for 30 minute. The anti-oxidative activities of curcumin, vitamin C and 
vitamin E were carried out at absorbance 750 nm for ABTS and 519 nm for DPPH assays, 
respectively. The measurements were carried out in an UV-Vis spectrophotometer. All 




4.4 Semen preparation 
The project protocol was approved by the Norwegian Regional Committee for Medical 
Research Ethics North Norway (REK nord: 2014/932). Written informed consent was obtained 
from all patients included in the study.  
 
 Fresh semen  
Semen samples were collected from the IVF patient at the IVF clinic at the University Hospital 
of North Norway (UNN) or from healthy men of age 20 to 40. Only semen samples having 
good motility and sperm concentration were used for the motility and viability enhancement 
experiments. The semen samples were collected from men who abstained ejaculation for a 
minimum of 3 to 5 days. The person carried experiments were blinded to the patient history. 
The detection of sperm quality were based on aggregation, concentration, morphology, motility, 
motility grade, pH, viscosity and volume after the criteria according to WHO guidelines (World 
Health, 2010).  
 
 Purified semen – The density gradient centrifugation method 
Semen sample was purified by the density gradient centrifugation method according to the 
guidelines at IVF clinic at UNN. Briefly, semen samples were freshly collected in the hospital. 
It was liquefied for 30 minute at room temperature with slow shaking. Semen sample (1 to 1.5 
ml) was applied in the upper layer (45 %) and lower layer (90 %) gradient solution each 1.5 ml 
in a 12 ml test tube. The samples were centrifuged 300-600 g in 10-20 minute. Two top layers 
or supernatant were discarded. Only purified semen with good quality from the bottom layer 
were collected and washed with sperm wash medium twice. 
 




The residue of the sperm cells was homogenized in a swim up medium containing human 
tubular fluid (HTF). After insemination at 13:00 at the IVF-clinic in UNN, the remaining 
samples were collected and used for the motility and viability enhancement experiments. 
 
4.5 Characterization of sperm cells 
 Total count concentration of sperm cells 
Semen samples (fresh or purified) were diluted 10 or 20 times (v/v) with methylene blue in a 
test tube and left for 10 minute. A capillary tube (VITREX Medical A/S, Denmark) was used 
to transfer some of the homogenized and diluted semen suspension over to an improved 0.1 
mm, 0.0025 mm2 depth counting chamber (Glaswarenfabrik Karl Hecht, Germany). The 
counting chamber was placed into the moist environment in a petri dish for 10 minute before 
total count was determined with the help of a Zeiss Standard Binocular microscope (Carl Zeiss, 
West Germany). Sperm cells were diluted to 1x105 cells/ml for the experiment later on. 
 
 Sperm motility and motility grade 
Motility and motility grade were determined after observing around 100 sperm cells in the 
inverted microscope (Wild Leitz, Germany). The categories of sperm movement were graded:  
0: no movement 
1: movement in a located area with no forward movement 
2: movement in small circles  
3: good movement either linearly forward or in large circle 





4.6 Preparation of anti-oxidant solutions and liposomal 
suspensions 
 The effect of saline and swim up HTF medium on human sperm cells 
Saline (0.9 % NaCl) were diluted to the final concentrations; 0, 8, 113, 135, 169, 203, 225, 338, 
405, 450, 675 and 810 µg/ml with HTF medium. 
 
 Dilution of anti-oxidant solutions and liposomal suspensions 
Two methods of dilutions were used to find the effect of anti-oxidants, empty liposomes and 
liposomal curcumin on human sperm cells. 
 Method 1: Sperm viability 
Liposomes were prepared as previously described in Section 4.1. Stock solutions of 2, 2, 10 20 
mg/ml of lipid in empty liposomes and liposomal curcumin were prepared. Each of the stock 
solutions were diluted 10, 100, 200, 400 and 600 times with swim up medium containing HTF. 
Each diluted liposomal suspension (2 µl) were added into 198 µl of 1x105 sperm cells/ml in a 
FALCON® 96-Well cell culture plates (Corning Incorporated, USA) (Figure 18) with two 
replicates.  
The final concentrations were of lipid were: 0.03, 0.05, 0.08, 0.10, 0.13, 0.17, 0.20, 0.25, 0.50, 
1, 2, 5, 10, 20 µg/ml. The curcumin-lipid ratio was 1:10 (w/w).  
The plates with sperm and liposomal suspension were incubated in a FormaTM Series II 3110 
Water-Jacked CO2 incubator (Thermo Scientific, USA) for 24 hours in 37 °C and 5 % CO2 
atmosphere before observation in inverted microscope as described in Section 4.5.2. 
 




 Method 2: Sperm viability 
Stock solution of empty liposomes and liposomal curcumin were prepared as previously 
described in Section 4.1. Each lipid suspension (10 µl) were diluted to 1 ml in fertilization 
medium to prepare 200 ng/µl. Each of the suspensions were diluted to 20, 40, 200 and 400 times 
with fertilization HTF medium to obtain final concentration as 10, 5, 1 and 0.5 µg/ml. Each 
suspension (10 µl) was added into 90 µl sperm cell suspension with 1x105 sperm cells/ml 
concentration. 
Stock solution of curcumin, ascorbic acid and α-tocopherol each with 10 mg/ml, were made in 
DMSO (curcumin and vitamin E) or HTF medium (vitamin C). Each stock solution of the anti-
oxidant was diluted 1, 2, 10 and 20 times with fertilization medium containing HTF to obtain 
final concentration as 10, 5, 1 and 0.5 µg/ml. 
Anti-oxidant solution (10 µl) was added to 90 µl of 1x105 cells/ml sperm cell suspension 
(Figure 19) and incubated at same condition as previously described (4.6.2.1). 
 
Figure 19: Method 2: Preparation of semen cell suspension for tolerance and toxicity determination. 
 
 Sperm motility and viability with anti-oxidants and liposomes 
Stock solutions of empty liposomes and liposomal curcumin were prepared as previously 
described in Section 4.1. Stock solutions of curcumin and α-tocopherol were prepared by 





































Every stock solution were diluted 500 times with HTF. Anti-oxidant solution or (2 µl) was 
added 198 µl of 1x105 cells/ml sperm suspension in 96-Well cell culture plate (Figure 20). 
Fresh semen as described in Section 4.4.1 was used in this experiment. It was carried out two 
replicates. 
 
Figure 20: Preparation of semen suspension for determination of sperm motility and viability. 
 
The suspension was prepared 2-4 hours after hand in from donor. The plates with suspension 
were incubated in a FormaTM Series II 3110 Water-Jacked CO2 incubator (Thermo Scientific, 
USA) for around 24 hours in 37 °C and 5 % CO2 atmosphere before observation in the inverted 
microscope as described in Section 4.5.2. 
 
4.7 Statistical methods 
All the results are expressed as mean ± SD from at least two or three independent experiments. 
The significance of the variability was determined with student t-test for the comparison of two 





5 RESULTS AND DISCUSSION 
Current project was focused on the development of liposomal formulation as carrier system for 
anti-oxidant destined for enhancing sperm cells motility and viability. Therefore, a simple but 
important anti-oxidant, curcumin, was selected for optimize its liposomal formulation. It is a 
well-known fact that oxidative stress in the sperm cells is induced by the free radicals produced 
endogenously or exogenously (Figure 14). In this respect, curcumin is one of the widely 
discussed and clinically relevant substance due to its free radical scavenging properties. 
Therefore, it was also necessary to examine the anti-oxidative activity of curcumin compared 
to vitamin C and vitamin E and their effect on the sperm cells motility and viability before 
optimization of liposomal formulations with curcumin.  
 
5.1 Liposomal formulation 
For the preparation of empty liposomes, approximately 200 mg lipids were used. In case of 
liposomal curcumin, approximately 200 mg of lipid and 20 mg of curcumin were used. Each 
formulation was prepared twice separately and summarized in Table 3. In all preparation 
curcumin-lipid ratio was 1:10 (w/w). 
Table 3: The contents of lipid and curcumin in different liposomal suspensions 
 Lipoid S100 (mg) Curcumin (mg) 
Empty liposomes 204 ± 1.4 - 
Liposomes with curcumin 201 ± 1.4 20.15 ± 0.1 
The values are presented as mean ± SD (n = 2). 
 
The size distributions can be presented by Gaussian distribution which measures a monomodal 
distribution, while NICOMP distribution measures a multimodal distribution of particle sizes. 
Sometimes, the vesicle sizes have multimodal distribution. In this case, calculating the mean 
size of the whole distribution gives a very inaccurate size and the NICOMP function should be 
used instead. Chi square (χ2) is used to describe if the observed size distribution are fit with the 
expected distribution. If the χ2 is between 0-2, the Gaussian analysis should be used. A value 





Sonication reduces MLVs to oligolamellar liposomes and SUVs through pulsed input of high 
energy (New, 1990). Extrusion is an easy, effective and gentle method to reduce liposomal size 
(Spuch and Navarro, 2011). Extrusion through polycarbonate membranes in general results in 
vesicles with a mean size smaller than the pore size in the membrane filter (New, 1990). 
In our case, the original liposomes prepared by the film method before sonication or extrusion 
had vesicle size around 1 µm. The sonication reduced the vesicle sizes of empty liposomes and 
liposomal curcumin significantly, however the polydispersity values were rather high. It was 
therefore decided to use extrusion method instead and results are presented in Table 4 are for 
the extruded liposomes. 
Table 4: Characterization of liposomes 










65.68 ± 4.7 0.3 ± 0.0 - -1.78 ± 0.1 
Liposomes 
with curcumin 
147.82 ±17.3 0.2 ± 0.1 88.8 ± 2.3 % -3.83 ± 0.8 
The values are presented as the mean ± SD (n = 2). 
 
Extrusion reduced the vesicle sizes to 65.68 ± 4.7 nm for empty liposomes and 147.82 ± 17.3 
nm for liposomes with curcumin (Table 4). The vesicle size of the extruded empty liposomes 
was smaller than the membrane pore size of 100 nm used in the extrusion which is in agreement 
with literature (New, 1990). However, for liposomes with curcumin, the vesicles were not 
smaller than 100 nm (Figure 21). This was somehow expected since we experienced the 
difficulties reducing these liposomes by sonication as well. It is evident that incorporation of 
curcumin in liposomal bilayers makes the bilayers more rigid resisting the size reduction. 
Curcumin is a relatively big molecule (MW 368) (Table 1) (Padhye et al., 2010). It consists of 
two benzene rings and has a conjugated structure which gives a planar structure. The conjugates 
make the molecule rigid forming more rigid bilayer membrane compared to a pure phospholipid 
bilayer membrane. The branch-structure of curcumin in its planar or bend shape is thought to 
be space consuming (Barry et al., 2009), explaining why liposomes with curcumin were larger 





Figure 21: Mean vesicle size of liposomes before and after extrusion. 
The values are presented as the mean ± SD (n = 2). 
 
In this case, the χ2 of empty liposomes ranged from 31.5 to 96.7 which indicates multimodal 
distribution of particle sizes. The NICOMP analysis should have been used instead of the 
Gaussian analysis. Taking in consideration that around 77 % of the vesicles in the empty 
liposomes had sizes around 96 nm as shown in Table 5, the Gaussian analysis were decided to 
be used so it could be compared to liposomal curcumin. It was considered that the amount of 
vesicles around 26 nm could not have big influence on the results, even though the mean size 
of empty liposomes in Table 4 in theoretical should be bigger. However, the size of the empty 
liposomes are still under 100 nm which were the preferred size for this experiment. 
Table 5: The vesicle sizes of empty liposomes based on the NICOMP analysis. 
Peak 1: Mean 
vesicle size (nm) 
Peak 1: Percentage 
%) of total 
distribution 
Peak 2: Mean 
vesicle size (nm) 
Peak 2: Percentage 
%) of total 
distribution 
26.18 ± 3.8 22.65 ± 4.3 96.25 ± 20.3 77.36 ± 4.2 































The high energy transferred to the liposomal curcumin during sonication lead to over 50 % 
volume loss of suspension (data is not shown). This was another reason why the extrusion 
method was preferred in the current project. Extrusion gave around 20 % suspension loss, which 
was considerable a lot less. 
Table 6: Volume loss of liposomal curcumin during extrusion. 
Volume of liposomal curcumin before extrusion 20 ml 
Volume of liposomal curcumin after extrusion 15.5 ml 
Volume lost during extrusion 4.5 ml 
Percentage lost volume during extrusion 22.5 % 
Theoretical amount of lost curcumin during extrusion 4.5 mg 
 
The polydispersity index (PI) is used to describe the distribution of vesicle sizes, where PI over 
0.3 in this case was considered as a broad distribution, and PI under 0.3 is considered a 
homogenous size distribution. The empty liposomes had a PI around 0.3 and 0.2 for liposomes 
with curcumin as shown in Figure 22 and Table 4. 
 
Figure 22: The effect of extrusion on the polydispersity of liposomes. 



























Sonicated empty liposomes were compared to extruded empty liposomes to see if the size 
reduction methods had an influence on the polydispersity of the vesicles. The vesicles were 
significantly (p = 0.01) more uniform for the extruded liposomes as shown in Table 7.  
Table 7: The effect sonication and extrusion have on the polydispersity of empty liposomes  
 Probe sonicated liposomes Extruded liposomes 
Polydispersity index 0.4 ± 0.1 0.3 ± 0.0 
The values are presented as mean ± SD (n = 2). 
 
Curcumin is suggested to be inside the phospholipid layer of liposomes and contributes to 
ordering the membrane. The interaction happen through hydrogen bonding with the choline 
group in the head of phospholipid and van der Waals bindings between the aromatic rings with 
the phospholipid acyl chains (Barry et al., 2009).  
The entrapment efficiency of curcumin in liposomes were found to be 89 % as shown in Table 
4. This was slightly higher, but similar to the findings as previously reported (Hussain, 2010). 
In his work he applied sonication as the intention to reduce vesicle size, whereas we used the 
extrusion. The ratio between the lipid and curcumin also differed between two projects. In 
another study by Basnet et al., it was found EE to be 82.1 ± 3.2 % and 67 ± 5.9 % for liposomes 
with starting amount of curcumin at 5 and 10 mg (Basnet et al., 2012). The equation used for 
calculating EE in the study was different from the one used in this experiment. When the EE 
was recalculated to the same equation as Basnet et al., EE was found to be 59.2 ± 7.8 %. This 
finding supports that the EE of curcumin decreased when higher amount of curcumin are added 
during the preparation and that actual values are best presented as microgram of curcumin per 
mg of lipid. 
Hussain also described that recovery of the liposomal curcumin was between 80 and 90 % 
(Hussain, 2010). In our case, the recovery was found to be 66.5 ± 7.1 % which is much lower, 
but can be explained. After the extrusion, the total amount of curcumin in the liposomal 
suspension was no longer 20 mg because some curcumin was lost during the extrusion.  
Since the remaining volume after extrusion was about 22.5 % less than the original (Table 6), 
recalculated recovery was 81.3 ± 16.1 %. This supports the findings of Hussain even though 




assumed that the volume loss only lead to curcumin loss. It was not taken considerations to lipid 
loss which can have happened. 
 
The expected zeta potential for the liposomes was zero because the compounds 
(phosphatidylcholine and curcumin) used in the liposomal preparation were not charged or 
zwitterionic (Pasenkiewicz-Gierula et al., 1999). The slightly negative zeta potential at -1.78 ± 
0.1 for empty liposomes and -3.83 ± 0.8 for liposomal curcumin (Table 4) were supported by 
Andersen et al. (Andersen et al., 2015). The small difference in zeta potential are due to 
experimental set up or maybe lipid oxidation to air (Fiume, 2001). The slightly negative zeta 
potential was not taken in account during further testing of the SUVs because slightly negative 
surface of liposomes tend to interact better with cells and increases endocytosis by target cell 
(Allen and Cullis, 2013). Since the purpose of this thesis is to see if the uptake of curcumin 
improves, the slightly negative charge was considered favourable. 
Studies show that curcumin has poor bioavailability because of limited absorption, rapid 
metabolism and rapid clearance and elimination from the body (Sharma et al., 2005, Anand et 
al., 2007, Wang et al., 2014). Poor bioavailability is one of the reasons why the potential of 
curcumin could not be fully utilized (Gupta et al., 2012). Nanotechnology was used for the 
purpose of changing the poor solubility and homogenous distribution of curcumin molecules as 
can be observed by naked eye (Figure 23). 
 
Figure 23: Bottle to the left contains curcumin in water. Bottle to the right contains curcumin entrapped in 




Higher cellular uptake is observed when the solubility increase. The increased solubility of 
curcumin was observed after incorporation in liposomes as shown in Figure 23. The bottle on 
the left contains a particular amount of curcumin mixed with water which could not be 
solubilized even after constant shaking. After using nanotechnology by incorporating the 
curcumin in liposomes, the curcumin was distributed homogenously, giving a homogenous 
suspension.  
 
5.2  Spectral analysis of curcumin 
The quantitative estimation of curcumin was carried out by UV-Vis methods taking curcumin 
as standard. To understand the maximal absorbance peak of curcumin (λmax), a spectral analysis 
of curcumin was performed (Figure 24). 
 
Figure 24: UV-Vis spectrum of curcumin dissolved in 96 % ethanol. 
 
The spectral analysis gave a maximum absorption peak (λmax) around 428 nm as shown in 
Figure 24, indicating that absorbance of curcumin in between 420-430 nm can be used for the 





5.3 Standard curve of curcumin 
Based on Beer-Lamberts law, the absorbance is proportional to a substance concentration which 
can absorb electromagnetic radiation. In order to quantify entrapment efficiency of curcumin, 
the amount of entrapped curcumin in the liposomal vesicles had to be quantified. For this 
purpose, a standard curve of curcumin was needed. By measuring the absorbance of a test 
sample knowing the absorbance in different concentrations, it is possible to use determine the 
concentration of the sample by using Beer-Lamberts law (Grøn, 2005). 
The standard curve for curcumin was prepared by measuring λmax at the wavelength of 425 nm 
as shown in Figure 25. A standard curve with good correlation (R2 = 1.00) was obtained. The 
equation (y = 0.0002x – 0.0023) was used to calculate the curcumin amount in the liposome. 
 
Figure 25: Standard curve of curcumin in 96 % ethanol. The small standard deviations are not shown in the graph. 
  























5.4 Stability testing of liposomes with curcumin 
To determine if vesicle size and polydispersity of liposomes with curcumin changed during the 
storage, two liposomal suspensions were measured after 5 months at 4 °C (Table 8). The mean 
diameter of the vesicles and polydispersity seemed smaller after the storage than before. 
However, student t-test was performed and showed no significant differences (p = 0.32). This 
indicated that the liposomes with curcumin were stable during storage, which is important 
parameter in the optimization of their characteristics.  
Table 8: Comparison of vesicle sizes of liposomes with curcumin after 5 months of storage in refrigerator at 4°C. 





after 5 months 
Polydispersity 
index (P.I) 
161.17 ± 17.46 0.10 ± 0.01 154.77 ± 16.71 0.09 ± 0.01 
The values are presented as mean ± SD (n = 2) with three replicates. 
 
5.5  Anti-oxidative activities of curcumin, vitamin C, vitamin E 
Anti-oxidative activities of curcumin was expressed as the capacity to scavenge the stable free 
radicals generated in the laboratory chemically. For this purpose cationic free radical ABTS 
(ABTS+•) and neutral free radical DPPH (DPPH•) were used. The concentration of ABTS+• and 
DPPH• is directly correlated to deep green and deep violet colour, respectively. Therefore the 
concentration can be measured by UV-Vis spectrophotometer. The chemical reactions of these 
radicals towards anti-oxidants are almost equivalent to those of the biologically generated free 
radicals such as super oxide, nitric oxide, peroxynitrite and hydroxyl radicals (Kedare and 
Singh, 2011).  
When ABTS+• or DPPH• are mixed with anti-oxidants, these radicals are easily reduced to 
ABTS or DPPH which are colourless. Based on this principle, ABTS+• and DPPH• solutions 
are widely used methods to determine the anti-oxidative activities of different substances 
because of its accuracy, easiness and inexpensiveness (Re et al., 1999, Erel, 2004, Kedare and 





 Spectral analysis of ABTS+• and DPPH• 
A complete spectra of ABTS+• or DPPH• radical solutions were measured (Figure 26 and Figure 
27). Both spectra were measured taking 96 % ethanol as blank and all sample solution were 
diluted in the ethanol. Complete UV-Vis spectra of ABTS+• or DPPH• radical solutions revealed 
the ideal concentration of the free radicals and λmax position which were important to know 
before anti-oxidant reaction. Spectral analysis, can help to decide and select absorbance for the 
quantitative measurements without UV-Vis crossover interferences.  
 
Figure 26: UV-Vis spectrum analysis of ABTS+• in 96 % ethanol. 
 
 





The spectral analysis of the ABTS+• showed the maximal absorbencies (λmax) at 647, 752 and 
840 nm as shown in Figure 26. For DPPH•, λmax was found at 518 nm as shown in Figure 27. 
The maximum absorbance measured for curcumin is at 428 nm (Section 5.2), for α-tocopherol 
at 295 nm and for ascorbic acid at 260 nm (Karpińska et al., 2005, National Center for 
Biotechnology Information, 2015a). Therefore, anti-oxidative activity were measured for 
ABTS+• and DPPH• solutions at 750 nm and 519 nm, respectively. 
 
 Free radical scavenging capacity of vitamin C, vitamin E and curcumin 
Curcumin was tested for its anti-oxidative activities comparing to ascorbic acid and α-
tocopherol because of their known anti-oxidative activities. The chemical structure of curcumin 
also resemble ascorbic acid and α-tocopherol (Buettner, 1993). 
Curcumin is similar to α-tocopherol structurally because of the phenolic ring with a long 
carbon-chain like curcumin. Instead of two phenolic rings on each end as curcumin, α-
tocopherol has only one. The molecule weight of α-tocopherol (MW: 430) is closer to curcumin 
(MW 368) (National Center for Biotechnology Information, 2015a)  
Ascorbic acid consists of a furan ring. The molecular size of ascorbic acid (MW: 176) is much 
smaller than curcumin (National Center for Biotechnology Information, 2015b). However, both 
vitamin C and curcumin can scavenge free radicals with almost similar potential (Figure 28 and 
Figure 29). 
Free radical scavenging capacity of vitamin C, vitamin E and curcumin were measured at 0.5, 
2.5, 5 and 10 µM concentration under similar conditions. All three anti-oxidants showed the 
concentration dependent radical scavenging activities. The results are shown in Figure 28 and 
Figure 29. The higher the concentrations were of the substances, the more free radicals were 





Figure 28: DPPH radical scavenging activities of ascorbic acid, a-tocopherol and curcumin in 96 % ethanol. 
The regression equations for DPPH radicals scavenging activity for vitamin C and vitamin E 
and curcumin are shown in Figure 28. In this experiment, vitamin C showed slightly steeper 
slope indicating that vitamin C had the strongest anti-oxidative activity among the three. 
 
Figure 29: ABTS radical scavenging activities of ascorbic acid, α-tocopherol and curcumin in 96 % ethanol. 
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The regression equations for ABTS radicals scavenging activity for curcumin, vitamin C and 
vitamin E are shown in Figure 29. It was found that the slope for curcumin was the steepest of 
all the slopes in the ABTS solution, indicating curcumin is strongest ABTS radical scavenger. 
Ak and Culcin reported that α-tocopherol had a steeper slope than curcumin in both ABTS+• 
and DPPH• solution (Ak and Gulcin, 2008). It should be noted that the anti-oxidant activity are 
comparatively similar for all three anti-oxidants. 
A student t-test were performed in this experiment to see if there was a significant difference 
among curcumin, vitamin C and vitamin E for their anti-oxidative activity. The results showed 
no significant difference between the anti-oxidants (p ≥ 0.12) giving no grounds to say if one 
anti-oxidant is better than another. This experiment confirmed that all the three anti-oxidants 
were very potent radical scavenger. 
 
 Half maximal effective concentration of vitamin C, vitamin E and 
curcumin 
The half maximal effective concentration (EC50) describes the concentration of substrate that 
expresses 50 % reduction of free radical as measured by decreased colour intensity. The lower 
EC50 mean higher radical scavenger activity.  
 



























The EC50 for curcumin were 5.82 µM for ABTS
+• solution and 9.13 µM for DPPH• solution as 
shown in Figure 30. The results are very similar to the previously published results (Basnet et 
al., 2012). Ak and Gulcin reported that the EC50 for curcumin to be 34.86 µg/mL (94.63 µM) 
in DPPH and 18.07µg/mL (49.05 µM) in ABTS for curcumin. The EC50 in this study are 
roughly 10 times higher than what was found in our experiment (Ak and Gulcin, 2008). It might 
be due to the purity of samples or dilution errors but our results are reproducible and similar to 
several other published results. 
 
5.6 The effect of saline and HTF on human sperm cells 
The effect of various dilutions of saline and swim up medium containing HTF was studied to 
find the optimal condition for controls. Motility and viability is highly reduced if only saline is 
used (data is not shown). As saline concentration was reduced and swim up medium-HTF alone 
was used, a constant viability was observed. The results in Figure 31 showed that swim up 
medium-HTF did not affect the sperm viability within 24 hours after various sperm cell 
concentrations. 
 
Figure 31: The effect of saline and swim up medium on sperm viability in vitro. 
 






























It was seen that the trend was slightly decreased when proportion of saline increased (Figure 
31). A-t-test were used to determine if there was a significant difference in longevity for high 
and low concentrations of saline. 
The concentrations 0 to 405 µg/ml were compared to the concentrations 405 to 810 µg/ml, and 
no significant difference were found (p = 0.85). Since the proportion of HTF medium are 
proportional to concentration of NaCl, this indicated that lower saline did not affect the viability 
of sperm cells. However, only swim up medium-HTF were chosen to be used for further 
experiments. 
 
5.7 Effects of anti-oxidants and liposomal curcumin on sperm cells 
One of the main purposes of the current research work was to establish the methodology. As 
stated previously, the objective of the study was to observe whether liposomal formulations 
show the in vitro enhanced effects on the motility and viability to the sperm cells. Three well 
known anti-oxidants, curcumin, vitamin C and vitamin E were selected for the study. These 
anti-oxidants were directly applied to the sperm cells taking dissolving solvents as the controls. 
In addition, curcumin was incorporated into liposomal vesicles to prepare liposomal curcumin. 
To observe the effects of liposomal curcumin, it was compared with the effect of empty 
liposomes taking as the controls. More over the effects of the liposomal curcumin were also 
compared with that of the directly applied anti-oxidants. Therefore, several independent 
methods were carried out based on hit-and-trial. At present, two separate methods are 
performed. 
 
 Method 1: Sperm viability 
Without knowing the therapeutically effective concentration of curcumin on sperm cells, it was 
carried out different dilutions of empty liposomes and liposomal curcumin to find the optimal 
concentrations. Details of the dilutions were carried out as shown in Section 4.6.2.1.The results 
are expressed after 24 hours of exposure of liposomal curcumin comparing to control with only 





Figure 32: The effect of liposomal curcumin on sperm viability in vitro. 
 
When empty liposomes were diluted with HTF medium, the viability of sperm cells raised 
drastically as shown in Figure 32. Low concentrations of lipid seemed to have highest viable 
sperm cells. When the concentration increased, the viability was observed decreased to 
concentrations 0.5 µg/ml. In concentrations higher than 0.5 µg/ml showed no viability at all.  
For empty liposomes, around 0.4 µg/ml reduced less than 90 % viability as shown in Figure 
32. Moreover as the concentrations were at 0.2 µg/ml or lower, more than 30 % sperm cells 
were alive.  
Similar results were found for the liposomal curcumin (Figure 32).In this case of liposomal 
curcumin, the amount of lipids were the same as the empty liposome but in addition to lipid, 
curcumin was added. A t-test showed no significant difference (p = 0.069) for empty liposome 
and liposomal curcumin. 
It is unlikely that soy lecithin, which consists of phosphatidylcholine (PC) was found toxic at 
0.5 µg/ml concentration to sperm cells. Soy lecithin is confirmed safe by the World Health 
Organization (WHO) and have been awarded Generally Recognized as Safe (GRAS) status by 
the US Food and Drug Administration (FDA) (World Health, 1974, Fiume, 2001). Therefore a 


























Few safety studies have been carried out on sperm cells, but PC concentrations up to the 100 
µg/ml have found no impact on sperm motility. PC have instead been found to have important 
functions for the acrosomal reaction (Cross, 1994). Lecithin which consists of PC has also 
shown effective supplement to reduce risk of contamination during sperm freezing (Jeyendran 
et al., 2008). 
In an article by Hong et al., it was found that PC concentration from 100 to 3000 µM showed 
no significant effect on human sperm motility (Hong et al., 1986). In this experiment, the toxic 
concentrations for empty liposomes were found at 0.5 µg/ml (approximately 0.66 µM) PC. An 
explanation of this can be the liposomal formulation. In Hong’s experiment, the PC were 
dissolved in chloroform, evaporated under nitrogen to prepare film of lipid in the test tube. It 
might be due to the lipid concentration were not distributed thoroughly to the sperm cells. In 
contrary, we were using liposomal particle of lipids with size smaller than 100 nm, therefore it 
may due enhanced cellular absorption. It is an interesting observation but needed further study 
to clarify.  
It is known fact that high body mass index (BMI) is correlated to various diseases including in 
changing certain hormones. Total sperm count have been found to be reduced and sperm cells 
abnormality in the person having higher BMI (Jensen et al., 2004). Another study shows sperm 
DNA and pregnancy outcome improves significantly by reducing abdominal fat (Faure et al., 
2014). Total concentration of sperm cells is also found to be directly correlated with the intake 
of saturated fat (Jensen et al., 2013). All the articles suggested that optimal sperm quality 
somehow depend on body fats. 
It is important to mention that the sperm used for current experiment were from different 
individuals. Therefore biological response may vary significantly as shown in Figure 32. Based 
on each donor’s personal life and habitat, the sperm quality can behave differently. These data 
were preliminary and sperm donors were blinded.  
When working with sperm, it is important to always mention time after semen collection. The 
longer time the sperm suspension are at temperatures out of 37 °C range, the fewer living sperm 
cells will be found in the suspension. A big factor contributing to this is pH. A normal pH range 
is specified to be around 7.2. When the semen leave the male body, the pH increases with time. 
A pH outside the normal range is harmful  to sperm (World Health, 2010). An evaluation of 
viability after 24 hours of incubation is therefore not a good enough estimation since the starting 




However, the sperm used in this experiment were samples given from the IVF-clinic at the 
University Hospital of North Norway (UNN). The semen that was used had a good quality with 
80 – 90 % alive sperm cells. With this in mind, it was assumed that the starting point of every 
suspension was the same even though more adjustment should have been done if this research 
will carry on. 
In summary, these preliminary data showed that the viability of the sperm cells improved only 
at lower lipid concentrations. The same results were found for liposomal curcumin. It is difficult 
to confirm if the viability is increased by curcumin alone, lipid only or both. But it was seen 
that the percentage of viable sperm cells were significantly raised when the concentrations of 
lipid were reduced. 
 
 Method 2: Sperm viability 
In this method, similar experiments were carried out as described previously. Instead of using 
swim up medium-HTF as method 1, it was used Protein Plus Fertilizing HTF medium. 
Application of liposomes and dilutions were carried out as mentioned in experimental Section 
4.6.2.2.The effect of curcumin, vitamin C, vitamin E and liposomal curcumin on sperm motility 
and viability were observed manually under the light microscope. Empty liposome was taken 
as control for liposomal curcumin. 
 



































As seen in Figure 33, curcumin, ascorbic acid and α-tocopherol had the similar trend, while use 
of empty liposomes and liposomal curcumin decreased sperm cells viability. Liposomal 
formulation showed the increased viability on sperm cells comparing to empty liposome. T-test 
was used to determine if some of the anti-oxidants affected the viability of sperm cells 
significantly. 
For the anti-oxidants that were used directly, had a relatively unchanged viability at 
concentrations up to 10 µg/ml and was significantly different at a 95 to 99 % confidence level 
from the liposomal formulations as shown in Figure 33. The findings of vitamin C and vitamin 
E were as expected. For instance, lower ascorbic acid concentration is found in the seminal 
plasma of infertile men compared to fertile men, indicating it’s important function for male 
fertility (Lewis et al.). Addition to that, ascorbic acid also improved the motility and viability 
of human sperm cells (Verma and Kanwar, 1998), and prevented sperm DNA damage (Hughes 
et al., 1998).  
α-Tocopherol has also shown protective role on human sperm cells as found in different clinical 
studies. Most of them imply that α-tocopherol can improve sperm viability, membrane integrity, 
motility and morphology (Agarwal et al., 2003, Lanzafame et al., 2009, Bansal and Bilaspuri, 
2010). α-Tocopherol has also a positive effect on the DNA oxidation (Hughes et al., 1998), and 
in a placebo controlled double-blind study, male with asthenozoospermia increased sperm 
motility after administrating α-tocopherol 100 mg daily for 6 months, and the pregnancy rate 
was increased (Suleiman et al., 1996).  
The influence of curcumin on sperm cells is not known so far. However, curcumin is found as 
a potent as vitamin C or vitamin E. Although, it is very preliminary report, it seems like the 
toxicity of the lipid can be reduced with the presence of curcumin. There were found significant 
differences at 95 % confidence level between empty liposomes and liposomal curcumin at 0.5 
µg/ml concentrations or higher as shown in Figure 33.The amount of lipid in the liposomal 
formulations had negative effect on the viability of sperm cells, while presence of anti-oxidant 
curcumin reduce that. It should be noted that the curcumin-lipid ratio was 1:10 (w/w). Further 
experiments are needed with protective effect of curcumin against lipid toxicity at higher 
concentration of curcumin. 
The results obtained in the method 1 and method 2 are compared in Table 9. Some different 





Table 9: Comparing the effect of liposomal formulations in method 1 and method 2.  











0 70 ± 0 60 ± 0 61.3 ± 8.5 61.3 ± 8.5 
0,5 0 0.4 ± 1 61.8 ± 7.2 65.0 ± 5.8 
1 0 0.1 ± 0.4 52.8 ± 6.3 62.8 ± 5.9 
5 0 0 42.8 ± 5.9 50.3 ± 2.2 
10 0 0 0.0 ± 0 18.0 ± 6.8 
The values are presented as mean ± SD (n ≥ 2) with two replicates. 
 
Dilution methods and medium were completely different in these two methods. In addition, due 
to increased working efficiency, sperm cells were exposed time outside the incubator is 
minimized while working in method 2. All these factors might contributed for different results. 
However, similar trends were observed in both methods as lipid concentration increased the 
viability of the sperm cells decreased. 
 
 Sperm motility and viability 
Concentration of the anti-oxidants were set as described previously in Section 4.6.3. The 
concentration of curcumin, ascorbic acid and α-tocopherol were set to contain same molarity 
curcumin in liposomal curcumin (Table 2). The semen suspensions were prepared 2.7 ± 0.8 
hours after hand in from donor. The observations were done 23 ± 0.9 hours after the treatment. 
During the observations, viability and motility grade were observed and results are presented 





Figure 34: The effect of anti-oxidant solutions and liposomal suspension on sperm motility and viability. The 
concentration of the lipid was 0.40 µg/ml for empty liposomes and liposomal curcumin. Concentration of curcumin 
was 0.04 µg/ml, 0.05 µg/ml for ascorbic acid and 0.02 µg/ml for α-tocopherol. 
 
The trend for all the tested liposomal formulations and anti-oxidants were very similar. Around 
50 % of the sperm cells were dead. 30 % of the alive sperm cells were in motility grade 1, and 
the remaining 20 % were accounted for motility grade 3 and 4. For correct method of counting, 
one could apply computer assisted sperm analysis (CASA). One of the limitations is due to the 
manual counting. For instance, it was seen that the sperm cells had a tendency to agglutinate to 
each other after 24 hours of incubation as shown in Figure 35. Further improvement in 

























Figure 35: Sperm agglutination observed in light microscope (x200). 
The large variation as seen by the big standard deviation clearly show that the number of 
samples has to be increased.  
In addition, it was used fresh semen directly without purification in this experiment. All 
ejaculates have a proportion of leukocytes, majorly of macrophages and neutrophils in the 
seminal plasma. They have high production of ROS which is not favourable on sperm 
functionalities (Bansal and Bilaspuri, 2010, Chen et al., 2013, Agarwal et al., 2014). Since the 
leukocytes were not removed in this experiment it may affect the results. Purified semen sample 
surely gave the better results.  
In summary, it was expected that at a concentration of 0.4 µg/ml lipid would give around 10 % 
viability because of Section 5.7.1. However, it was found around 50 % dead sperm cells, 30 % 
alive sperm cells in motility grade 1 and around 20 % were accounted for motility grade 3 and 
4. The trend for all the anti-oxidant solutions and liposomal suspensions were very similar. No 
significant differences were found between all of them (with or without liposomal formulation). 






The present research work was mainly focused on the effect of anti-oxidants on sperm cells 
motility and viability in vitro. A clinically potential anti-oxidant, curcumin was chosen because 
of its multi-targeted anti-oxidative and anti-inflammatory activities as well as high safety 
profile. However, because of poor solubility it could not be used directly. Therefore by the 
application of nanotechnology, liposomes incorporated with curcumin was prepared and 
optimized for such purpose. A method was developed for the preparation of liposomes with 
curcumin with the high size uniformity and high entrapment efficiency (>80 %). With extrusion 
method, the liposomes were found very monodispersed and uniform in size which was 
maintained for 5 months period of storage.  
Anti-oxidative activities of curcumin were examined with the radical scavenging capacity by 
ABTS and DPPH assay methods. The EC50 for curcumin were 5.82 µM for ABTS
+• solution 
and 9.13 µM for DPPH• solution, respectively. This result clearly showed that curcumin is as 
potent as widely discussed anti-oxidants such as vitamin C or vitamin E. All tested anti-oxidants 
namely curcumin, vitamin C and vitamin E improved the motility and viability of the sperm in 
this preliminary pilot study. 
Another interesting finding in this study was that liposomal formulations had negative effect 
on sperm motility comparing to curcumin. Empty liposomes were taken as the control for the 
liposomal curcumin and showed high level of toxicity to sperm cells at the concentration of 0.5 
µg/ml. Comparing to empty liposome, liposomal curcumin showed an increased motility at the 
same lipid concentration. This study clearly indicated a strong toxicity to the sperm cells by 
phosphatidylcholine at the concentrations more than 0.5 µg/ml. It was not clear whether such 
toxicity is due to particular lipid. Further studies are needed to explore and understand fully the 










The results found in this thesis are preliminary pilot study. Current study was the first of its 
kind and mainly focused on the experimental method developments. Curcumin seemed to 
enhance the motility and viability of human sperm cells in vitro probably due to its anti-
oxidative effect. Further studies on curcumin on larger scale with the formulation including 
other types of lipids are also necessary. It could also be interesting to see if the morphology of 
the sperm cells changes, not only observation of motility and viability. 
Liposomal formulation in certain concentrations had an impact on the viability of sperm cells. 
Taking in consideration that phosphatidylcholine was the dominant component in liposomes, 
this was an unexpected finding. Does this mean that soluble fat can affect the fertility? A 
focused study is necessary in order to link obesity and infertility.  
It would be interesting to see the effect of liposomes with other types of lipids. One should note 
that 44 % of the phospholipids found in seminal plasma contains sphingomyelin, while 
phosphatidylethanolamine contributes as the second most abundant lipid in seminal plasma and 
human sperm cells (Poulos and White, 1973). The literature states that 
phosphatidylethanolamine is drastically reduced in infertile men, while phosphatidylserine is 
significantly increased (Gulaya et al., 2001). If phosphatidylethanolamine is so important for 
fertility as the literature report, maybe a liposomal formulation with this phospholipid can open 
a new way of transporting reproductive at least by improving human semen quality. 
It is important to remember that this was an in vitro study, which was more relevant for ART. 
In vivo, the human body has a lot of physiological barriers like blood vessel wall, extracellular 
matrix and interstitial fluid pressure gradients, among many others. Nanoparticles/liposomes 
have to overcome these barriers before they can act on the target cells.  
Nanomedicine has shown a wide range of possibilities in diagnosis, treatment and prevention 
of diseases. Nanomedicine also reduces unwanted side effects. In spite of several possibilities 
and difficulties, nanotechnology is still evolving. With this in mind, a lot of ethical questions 
are raised whether it can have an impact on the normal evolution on humans.  
I would like to end this by reminding that nanomedicine gives unlimited opportunities for the 
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